|
|
|
|
Achieving strong container closure integrity today requires more than meeting a specification. A modern approach to CCI blends smart design, risk‑based strategies, and deterministic testing to safeguard sterile products. Examine how lifecycle thinking and practical sampling plans strengthen quality.
|
|
|
|
|
Microbial ingress testing has long been treated as a cornerstone of container closure integrity evaluation, yet its reliability continues to be challenged. Gain insight into why its variability and limitations demand a shift to deterministic methods that deliver accurate results.
|
|
|
|
|
Ensuring that sterile pharmaceutical products remain uncompromised starts with knowing exactly what size defect a container closure integrity (CCI) method can detect. Discover how test sensitivity, positive controls, and regulatory standards shape CCI strategies.
|
|
|
|
|
Autoinjectors introduce unique mechanical forces that traditional vial or syringe systems never had to withstand, and those forces can significantly alter how container closure integrity should be assessed. Explore why device complexity creates new risks and how testing strategies must adapt.
|
|
|
|
|
Dye ingress testing is often viewed as a simple way to evaluate package integrity, but its performance depends heavily on pressure behavior that shifts with viscosity. See how these constraints narrow its operating window and call into question its reliability for high‑risk applications.
|
|
|
|
|
Ensuring container closure integrity has never been more central to protecting parenteral drug quality. Review the critical factors that define a reliable container closure integrity method, as well as what truly distinguishes robust, reproducible testing in today’s demanding parenteral landscape.
|
|
|
|
|
|
|
